← Back to Bills
HR 4286118th CongressFailed / ExpiredHouse

Increasing Access to Lung Cancer Screening Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 20, 2024
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Increasing Access to Lung Cancer Screening Act (H.R. 4286) is a legislative proposal introduced in the 118th Congress aimed at improving access to lung cancer screening services. The bill was referred to the House Subcommittee on Health but did not advance further and is currently classified as failed or expired. Specific details about the bill's provisions, funding, or implementation mechanisms are not available in the provided source data.

Bottom Line

H.R. 4286 sought to enhance lung cancer screening access but did not progress beyond initial referral and has expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focuses on increasing access to lung cancer screening, a critical preventive health measure.
  • It was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health.
  • No detailed summary or full text is available, limiting insight into specific policy measures or funding.
Who Benefits?

['Individuals at risk for lung cancer who may gain improved access to screening services', 'Healthcare providers involved in lung cancer screening', 'Public health agencies focused on cancer prevention and early detection']

Potential Concerns

['Lack of available full text and summary limits understanding of implementation and funding mechanisms', 'Unclear oversight and enforcement provisions due to missing detailed legislative language', 'Potential cost implications for federal health programs or insurers are not specified']

Political Context

The bill was introduced in the 118th Congress and referred to the House Subcommittee on Health but did not advance further. It is currently classified as failed or expired. The absence of detailed legislative text and summary indicates limited legislative progress or debate on this measure during the session.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['Potential increased demand on healthcare providers and screening facilities if access is expanded', 'Possible shifts in public health resource allocation toward lung cancer screening programs', 'Improved early detection rates could influence lung cancer treatment outcomes and healthcare costs']

GovScope Watchdog Notes

The absence of a full bill text and official summary reduces transparency and limits the ability to fully assess the bill's scope, funding, and enforcement mechanisms. The bill's failure to advance beyond referral suggests limited legislative engagement, which is important for public understanding of congressional priorities and health policy development.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready